Janux Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	26.75	19.21	51.43	35.58	7.81	0.66
Short-Term Investments	631.28	324.82	275.59	339.38	-	-
Cash & Short-Term Investments	658.03	344.03	327.02	374.97	7.81	0.66
Cash Growth	88.16%	5.20%	-12.79%	4699.24%	1087.39%	-
Accounts Receivable	-	-	-	-	8	-
Other Receivables	4.45	2.2	0.7	0.2	-	-
Receivables	4.45	2.2	0.7	0.2	8	-
Prepaid Expenses	3.84	3.01	4.72	1.85	0.25	-
Total Current Assets	666.32	349.24	332.44	377.02	16.06	0.66
Property, Plant & Equipment	25.06	27.84	29.37	1.6	0.16	0.02
Other Long-Term Assets	3.64	3.33	2.21	1.21	-	-
Total Assets	695.02	380.41	364.01	379.82	16.22	0.68
Accounts Payable	2.46	2.42	2.16	2.46	0.43	0.27
Accrued Expenses	13.02	7.39	8.18	3.78	0.75	0.36
Short-Term Debt	-	-	-	-	-	4
Current Portion of Leases	1.69	1.52	0.76	0.19	-	-
Current Unearned Revenue	-	1.71	5.41	5.16	1.95	-
Other Current Liabilities	-	-	-	1.2	0.05	-
Total Current Liabilities	17.17	13.03	16.51	12.8	3.18	4.63
Long-Term Leases	21.74	23.03	24.54	-	-	-
Long-Term Unearned Revenue	-	-	2.22	0.7	6.05	-
Total Liabilities	38.92	36.06	43.27	13.5	9.23	4.63
Common Stock	0.05	0.05	0.04	0.04	0	0
Additional Paid-In Capital	865.76	512.4	432.7	413.97	0.1	0.01
Retained Earnings	-217.54	-168.76	-110.47	-47.41	-14.74	-7.96
Comprehensive Income & Other	7.83	0.67	-1.54	-0.27	-	-
Total Common Equity	656.1	344.35	320.74	366.33	-14.64	-7.94
Shareholders' Equity	656.1	344.35	320.74	366.33	6.99	-3.95
Total Liabilities & Equity	695.02	380.41	364.01	379.82	16.22	0.68
Total Debt	23.43	24.54	25.31	0.19	-	4
Net Cash (Debt)	634.6	319.49	301.71	374.77	7.81	-3.34
Net Cash Growth	95.37%	5.89%	-19.49%	4696.76%	-	-
Net Cash Per Share	12.39	7.26	7.28	15.93	8.54	-4.99
Filing Date Shares Outstanding	52.48	51.65	41.76	41.24	1.26	0.67
Total Common Shares Outstanding	52.33	46.24	41.62	41.24	1.26	0.67
Working Capital	649.15	336.21	315.93	364.22	12.88	-3.97
Book Value Per Share	12.54	7.45	7.71	8.88	-11.64	-11.87
Tangible Book Value	656.1	344.35	320.74	366.33	-14.64	-7.94
Tangible Book Value Per Share	12.54	7.45	7.71	8.88	-11.64	-11.87
Machinery	9.82	9.87	7.91	1.4	0.18	0.03
Construction In Progress	-	-	-	0.14	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.